Mullen competitive analysis

Latest publications and patents of Mullen New

Explore the latest publications and patents granted to Mullen, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Mullen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release TabletsGALENICUM HEALTH SLDec 19, 2020
Cancer TreatmentsNUCANADec 20, 2018
Pharmaceutical Compositions Comprising AripiprazoleNOBEL ILAC SANAYI VE TICARETJul 6, 2018

Latest PTAB cases involving Mullen

Discover the latest PTAB cases involving Mullen, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Mullen

IPR2025-00742Apr 6, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00745Apr 5, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00746Apr 5, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00743Apr 4, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00744Mar 27, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00740Mar 26, 2025META PLATFORMSMULLEN INDUSTRIESTrial Instituted
IPR2025-00741Mar 26, 2025META PLATFORMSMULLEN INDUSTRIESTrial Instituted
IPR2025-00738Mar 26, 2025META PLATFORMSMULLEN INDUSTRIESPending
IPR2025-00737Mar 25, 2025META PLATFORMSMULLEN INDUSTRIESTrial Instituted
IPR2025-00739Mar 25, 2025META PLATFORMSMULLEN INDUSTRIESPending

Peer Comparison New

IP litigation analysis comparing Mullen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MULLEN3 - - - Highly Aggressive
GALENICUM HEALTH SL112 - - Defensive
GALENICUM HEALTH SLU2712 - - Highly Aggressive
NOBEL ILAC SANAYI VE TICARET - 1 - - Non-Active